Eric Bjerkholt
Chief Financial Officer
CFO
Board Member
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Financial Officer | $520,000 | $3,246,216 |
| 2024 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Financial Officer | $500,000 | $2,006,255 |
| 2023 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Financial Officer | $151,562 | $4,337,928 |
| 2022 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Financial Officer | — | — |
Executive changes
Earnings-call appearances
-
Mirum Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 5, 20262026-08-05
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q1 FY2026 Earnings Call2026-05-06
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q4 FY2025 Earnings Call2026-02-25
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-11-04
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-08-06
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q1 FY2025 Earnings Call2025-05-07
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-01-13
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-11-12
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-05-08
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2024-02-28
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-11-02
Mirum Pharmaceuticals, Inc. (MIRM)